Literature DB >> 28667740

Functional melanoma-risk variant IRF4 rs12203592 associated with Breslow thickness: a pooled international study of primary melanomas.

D C Gibbs1, S V Ward2,3, I Orlow3, G Cadby2, P A Kanetsky4, L Luo5, K J Busam3, A Kricker6, B K Armstrong6, A E Cust6,7, H Anton-Culver8, R P Gallagher9, R Zanetti10, S Rosso10, L Sacchetto10,11, D W Ollila12,13, C B Begg3, M Berwick5, N E Thomas13,14.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28667740      PMCID： PMC5711542          DOI： 10.1111/bjd.15784

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  10 in total

1.  An efficient Monte Carlo approach to assessing statistical significance in genomic studies.

Authors:  D Y Lin
Journal:  Bioinformatics       Date:  2004-09-28       Impact factor: 6.937

2.  Inherited genetic variants associated with occurrence of multiple primary melanoma.

Authors:  David C Gibbs; Irene Orlow; Peter A Kanetsky; Li Luo; Anne Kricker; Bruce K Armstrong; Hoda Anton-Culver; Stephen B Gruber; Loraine D Marrett; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Terence Dwyer; Ajay Sharma; Emily La Pilla; Lynn From; Klaus J Busam; Anne E Cust; David W Ollila; Colin B Begg; Marianne Berwick; Nancy E Thomas
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-04-02       Impact factor: 4.254

3.  The association of host and genetic melanoma risk factors with Breslow thickness in the Western Australian Melanoma Health Study.

Authors:  G Cadby; S V Ward; J M Cole; E K Moses; M Millward; L J Palmer
Journal:  Br J Dermatol       Date:  2014-04       Impact factor: 9.302

4.  Allele-specific transcriptional regulation of IRF4 in melanocytes is mediated by chromatin looping of the intronic rs12203592 enhancer to the IRF4 promoter.

Authors:  Mijke Visser; Robert-Jan Palstra; Manfred Kayser
Journal:  Hum Mol Genet       Date:  2015-01-27       Impact factor: 6.150

5.  IRF4 rs12203592 functional variant and melanoma survival.

Authors:  Miriam Potrony; Aida Rebollo-Morell; Pol Giménez-Xavier; Lisa Zimmer; Joan Anton Puig-Butille; Gemma Tell-Marti; Antje Sucker; Celia Badenas; Cristina Carrera; Josep Malvehy; Dirk Schadendorf; Susana Puig
Journal:  Int J Cancer       Date:  2017-02-06       Impact factor: 7.396

6.  Vitamin D receptor polymorphisms in patients with cutaneous melanoma.

Authors:  Irene Orlow; Pampa Roy; Anne S Reiner; Sarah Yoo; Himali Patel; Susan Paine; Bruce K Armstrong; Anne Kricker; Loraine D Marrett; Robert C Millikan; Nancy E Thomas; Stephen B Gruber; Hoda Anton-Culver; Stefano Rosso; Richard P Gallagher; Terence Dwyer; Peter A Kanetsky; Klaus Busam; Lynn From; Colin B Begg; Marianne Berwick
Journal:  Int J Cancer       Date:  2011-04-25       Impact factor: 7.396

7.  Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways.

Authors:  David C Gibbs; Irene Orlow; Jennifer I Bramson; Peter A Kanetsky; Li Luo; Anne Kricker; Bruce K Armstrong; Hoda Anton-Culver; Stephen B Gruber; Loraine D Marrett; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Terence Dwyer; Ajay Sharma; Emily La Pilla; Lynn From; Klaus J Busam; Anne E Cust; David W Ollila; Colin B Begg; Marianne Berwick; Nancy E Thomas
Journal:  J Natl Cancer Inst       Date:  2016-02-08       Impact factor: 13.506

8.  Telomerase activity in prognostic histopathologic features of melanoma.

Authors:  Lucia Carvalho; Monica Lipay; Francisco Belfort; Ivan Santos; Joyce Andrade; Alessandra Haddad; Flavia Brunstein; Lydia Ferreira
Journal:  J Plast Reconstr Aesthet Surg       Date:  2006-04-03       Impact factor: 2.740

9.  Regulation of telomerase activity by interferon regulatory factors 4 and 8 in immune cells.

Authors:  Radmila Hrdlicková; Jirí Nehyba; Henry R Bose
Journal:  Mol Cell Biol       Date:  2008-12-01       Impact factor: 4.272

10.  An intronic polymorphism of IRF4 gene influences gene transcription in vitro and shows a risk association with childhood acute lymphoblastic leukemia in males.

Authors:  Thuy N Do; Esma Ucisik-Akkaya; Charronne F Davis; Brittany A Morrison; M Tevfik Dorak
Journal:  Biochim Biophys Acta       Date:  2009-11-06
  10 in total
  5 in total

1.  Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes.

Authors:  Nancy E Thomas; Sharon N Edmiston; Irene Orlow; Peter A Kanetsky; Li Luo; David C Gibbs; Eloise A Parrish; Honglin Hao; Klaus J Busam; Bruce K Armstrong; Anne Kricker; Anne E Cust; Hoda Anton-Culver; Stephen B Gruber; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Lidia Sacchetto; Terence Dwyer; David W Ollila; Colin B Begg; Marianne Berwick; Kathleen Conway
Journal:  J Invest Dermatol       Date:  2018-05-09       Impact factor: 8.551

2.  Germline variants are associated with increased primary melanoma tumor thickness at diagnosis.

Authors:  Ernest Mangantig; Stuart MacGregor; Mark M Iles; Richard A Scolyer; Anne E Cust; Nicholas K Hayward; Grant W Montgomery; David L Duffy; John F Thompson; Anjali Henders; Lisa Bowdler; Casey Rowe; Gemma Cadby; Graham J Mann; David C Whiteman; Georgina V Long; Sarah V Ward; Kiarash Khosrotehrani; Jennifer H Barrett; Matthew H Law
Journal:  Hum Mol Genet       Date:  2021-01-06       Impact factor: 6.150

3.  Association of Melanoma-Risk Variants with Primary Melanoma Tumor Prognostic Characteristics and Melanoma-Specific Survival in the GEM Study.

Authors:  Danielle R Davari; Irene Orlow; Peter A Kanetsky; Li Luo; Klaus J Busam; Ajay Sharma; Anne Kricker; Anne E Cust; Hoda Anton-Culver; Stephen B Gruber; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Lidia Sacchetto; Terence Dwyer; David C Gibbs; David W Ollila; Colin B Begg; Marianne Berwick; Nancy E Thomas
Journal:  Curr Oncol       Date:  2021-11-16       Impact factor: 3.677

4.  Association of IRF4 single-nucleotide polymorphism rs12203592 with melanoma-specific survival.

Authors:  S V Ward; D C Gibbs; I Orlow; N E Thomas; P A Kanetsky; L Luo; A E Cust; H Anton-Culver; S B Gruber; R P Gallagher; S Rosso; R Zanetti; T Dwyer; C B Begg; M Berwick
Journal:  Br J Dermatol       Date:  2020-02-19       Impact factor: 9.302

5.  Gene Expression and Mutational Profile in BAP-1 Inactivated Melanocytic Lesions of Progressive Malignancy from a Patient with Multiple Lesions.

Authors:  Yan Zhou; Andrew C Nelson; Yuyu He; Sarah A Munro; Kyu Young Song; Evidio Domingo-Musibay; Alessio Giubellino
Journal:  Genes (Basel)       Date:  2021-12-22       Impact factor: 4.096
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.